Progyny Q1 EPS $0.05 Beats $0.01 Estimate, Sales $172.22M Beat $166.23M Estimate; Sees Q2 Adj. EBITDA $28M-$30M, Sales $188M-$193M vs $189M Est.; FY22 Adj. EBITDA $111M-$122M, Sales $735M-$775M vs $754M Est.

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!